2004
DOI: 10.1001/archopht.122.6.813
|View full text |Cite
|
Sign up to set email alerts
|

The Ocular Hypertension Treatment Study

Abstract: Background: The prevalence of glaucoma is higher in African American individuals than in white individuals. Objective: To report the safety and efficacy of topical ocular hypotensive medication in delaying or preventing the onset of primary open-angle glaucoma (POAG) among African American participants in the Ocular Hypertension Treatment Study. Methods: Eligibility criteria included age between 40 and 80 years, intraocular pressure between 24 and 32 mm Hg in one eye and between 21 and 32 mm Hg in the other ey… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
31
0
1

Year Published

2004
2004
2015
2015

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 143 publications
(35 citation statements)
references
References 34 publications
3
31
0
1
Order By: Relevance
“…29,30 Results from the Ocular Hypertension Treatment Study suggest that a greater occurrence of CVD may be linked to the higher incidence of glaucoma in African Americans. 31 …”
Section: Discussionmentioning
confidence: 99%
“…29,30 Results from the Ocular Hypertension Treatment Study suggest that a greater occurrence of CVD may be linked to the higher incidence of glaucoma in African Americans. 31 …”
Section: Discussionmentioning
confidence: 99%
“…Intraocular pressure (IOP) is the major risk factor for glaucoma development and progression [1,2,3,4] and its thoughtful evaluation is therefore of crucial importance both at diagnosis and follow-up [5]. IOP reduction also reduces the effects of the disease on the visual field and optic nerve head [6,7], and as a consequence also the effects of IOP-lowering treatments need to be monitored over time.…”
Section: Introductionmentioning
confidence: 99%
“…There is evidence by multicenter, prospective randomized trials that reducing mean IOP is beneficial for reducing glaucoma progression [1,2,3,4]. Still, all these trials except one [3] relied on single IOP measurements performed at each visit, regardless of the large variations that frequently occur in glaucoma patients.…”
Section: Introductionmentioning
confidence: 99%
“…[10,11,18,19] Results from the Ocular Hypertension Treatment Study (OHTS) suggest that increased rates of cardiovascular disease in AD persons may be linked to increased rates of glaucoma. [20] Our study investigated OAG patients of AD and ED with respect to retinal capillary blood flow and it’s impact on glaucomatous ONH structural progression over time in patients currently free from these diseases.…”
Section: Discussionmentioning
confidence: 99%